Fibrous dysplasia: Pathophysiology, evaluation, and treatment

Journal of Bone and Joint Surgery

Volumn 87, Issue 8, 2005, Pages 1848-1864

  DiCaprio, Matthew R ^a   Enneking, William F ^b  

^a Schenectady Regional Orthopaedic Associates   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; PAMIDRONIC ACID; PROTEIN SUBUNIT; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; VITAMIN D; ZOLEDRONIC ACID;

BONE BIOPSY; BONE DEFECT; BONE DEFORMATION; BONE GRAFT; BONE MINERALIZATION; BONE NECROSIS; BONE PAIN; BONE RADIOGRAPHY; BONE REMODELING; BONE SCINTISCANNING; CANCELLOUS BONE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 20Q; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG INDICATION; FACIAL BONE; FIBROUS DYSPLASIA; FRACTURE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INCIDENTAL FINDING; LONG BONE; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATHOLOGIC FRACTURE; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; RIB; SIDE EFFECT; STRESS FRACTURE; TREATMENT INDICATION;

EID: 23044514005     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.D.02942     Document Type: Review

References (65)

1. Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg. 1938;36:874-98.
2. Lichtenstein L, Jaffe HL. Fibrous dysplasia of bone. A condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol. 1942;33:777-816.
3. Coley BL. Neoplasms of bone and related conditions; etiology, pathogenesis, diagnosis, and treatment. 2nd ed. New York: Hoeber; 1960.
4. Campanacci M. Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. 2nd ed. New York: Springer; 1999.
5. Enneking WF, Rathe R, Cornwall G. Clinical musculoskeletal pathology. CD-ROM version 1998 www release. Produced by the office of Medical Informatics at the University of Florida, http://www.medinfo.ufl.edu/cme/mspath/.
6. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulating G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325:1688-95.
7. Weinstein LS, Chen M, Liu J. Gs(alpha) mutations and imprinting defects in human disease. Ann NY Acad Sci. 2002;968:173-97.
8. Cohen MM Jr, Howell RE. Etiology of fibrous dysplasia and McCune-Albright syndrome. Int J Oral Maxillofac Surg. 1999;28:366-71.
9. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van-Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr. 1993;123:509-18.
10. Bianco P, Kuznetsov S, Riminucci M, Fisher LW, Spiegel AM, Robey PG. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest. 1998;101:1737-44.
11. Marie PJ, de Pollak C, Chanson P, Lomri A. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol. 1997;150:1059-69.
12. Yamamoto T, Ozono K, Kasayama S, Yon K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S. Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest. 1996;98:30-5.
13. Ding C, Deng Z, Levine MA. A highly sensitive PCR method detects activating mutations of the GNAS1 gene in peripheral blood cells of patients with McCune-Albright syndrome or isolated fibrous dysplasia. J Bone Miner Res. 2001;16(Suppl 1):S417.
14. Henry A. Monostotic fibrous dysplasia. J Bone Joint Surg Br. 1969;51:300-6.
15. Wirth WA, Leavitt D, Enzinger FM. Multiple intramuscular myxomas. Another extraskeletal manifestation of fibrous dysplasia. Cancer. 1971;27:1167-73.
16. Blasier RD, Ryan JR, Schaldenbrand MF. Multiple myxomata of soft tissue associated with polyostotic fibrous dysplasia. A case report. Clin Orthop Relat Res. 1986;206:211-4.
17. Harris WH, Dudley HR Jr, Barry RJ. The natural history of fibrous dysplasia. An orthopaedic, pathological, and roentgenographic study. Am J Orthop. 1962;44:207-33.
18. Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, Grill F, Lala R, Massobrio M, Pinggera O, Riminucci M, Snela S, Zambakidis C, Bianco P; European Pediatric Orthopaedic Society. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B. 2003;12:155-77.
19. Nakashima Y, Kotoura Y, Nagashima T, Yamamuro T, Hamashima Y. Monostotic fibrous dysplasia in the femoral neck. A clinicopathologic study. Clin Orthop Relat Res. 1984;191:242-8.
20. Kaplan FS, Fallon MD, Boden SD, Schmidt R, Senior M, Haddad JG. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). N Engl J Med. 1988;319:421-5.
21. Leet AI, Magur E, Lee JS, Wientroub S, Robey PG, Collins MT. Fibrous dysplasia in the spine: prevalence of lesions and associations with scoliosis. J Bone Joint Surg Am. 2004;86:531-7.
22. Frodel JL, Funk G, Boyle J, Richardson M. Management of aggressive midface and orbital fibrous dysplasia. Arch Facial Plast Surg. 2000;2:187-95.
23. Funk FJ Jr, Wells RE. Hip problems in fibrous dysplasia. Clin Orthop Relat Res. 1973;90:77-82.
24. Leet AI, Chebli C, Kushner H, Chen CC, Kelly MH, Brillante BA, Robey PG, Bianco P, Wientroub S, Collins MT. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res. 2004;19:571-7.
25. Wai EK, Davis AM, Griffin A, Bell RS, Wunder JS. Pathologic fractures of the proximal femur secondary to benign bone tumors. Clin Orthop Relat Res. 2001;393:279-86.
26. Enneking WF, Gearen PF. Fibrous dysplasia of the femoral neck. Treatment by cortical bone-grafting. J Bone Joint Surg Am. 1986;68:1415-22.
27. Guille JT, Kumar SJ, MacEwen GD. Fibrous dysplasia of the proximal part of the femur. Long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg Am. 1998;80:648-58.
28. Fitzpatrick KA, Taljanovic MS, Speer DP, Graham AR, Jacobson JA, Barnes GR, Hunter TB. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR Am J Roentgenol. 2004;182:1389-98.
29. Zhibin Y, Quanyong L, Libo C, Jun Z, Hankui L, Jifang Z, Ruisen Z. The role of radionuclide bone scintigraphy in fibrous dysplasia of bone. Clin Nucl Med. 2004;29:177-80.
30. Jee WH, Choi KH, Choe BY, Park JM, Shinn KS. Fibrous dysplasia: MR imaging characteristics with radiopathologic correlation. AJR Am J Roentgenol. 1996;167:1523-7.
31. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer. 1994;73:1411-24.
32. Huvos AG, Higinbotham NL, Miller TR. Bone sarcomas arising in fibrous dysplasia. J Bone Joint Surg Am. 1972;54:1047-56.
33. Yabut SM Jr, Kenan S, Sissons HA, Lewis MM. Malignant transformation of fibrous dysplasia. A case report and review of the literature. Clin Orthop Relat Res. 1988;228:281-9.
34. Coley BL, Stewart FW. Bone sarcoma in polyostotic fibrous dysplasia. Ann Surg. 1945;121:872-81.
35. Schwartz DT, Alpert M. The malignant transformation of fibrous dysplasia. Am J Med Sci. 1964;247:1-20.
36. Lopez-Ben R, Pitt MJ, Jaffe KA, Siegal GP. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome. Skeletal Radiol. 1999;28:522-6.
37. Ortiz EJ, Isler MH, Navia JE, Canosa R. Pathologic fractures in children. Clin Orthop Relat Res. 2005;432:116-26.
38. Campanacci M. Osteofibrous dysplasia of long bones a new clinical entity, Ital J Orthop Traumatol. 1976;2:221-37.
39. Campbell CJ, Hawk T. A variant of fibrous dysplasia (osteofibrous dysplasia). J Bone Joint Surg Am. 1982;64:231-6.
40. Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn. 2000;2:67-72.
41. Maki M, Saitoh K, Horiuchi H, Morohoshi T, Fukayama M, Machinami R. Comparative study of fibrous dysplasia and osteofibrous dysplasia: histopathological, immunohistochemical, argyrophilic nucleolar organizer region and DNA ploidy analysis. Pathol Int. 2001;51:603-11.
42. Hazelbag HM, Taminiau AH, Fleuren GJ, Hogendoorn PC. Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am. 1994;76:1482-99.
43. Maki M, Athanasou N. Osteofibrous dysplasia and adamantinoma: correlation of protooncogene product and matrix protein expression. Hum Pathol. 2004;35:69-74.
44. Bertoni F, Bacchini P, Fabbri N, Mercuri M, Picci P, Ruggieri P, Campanacci M. Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma. Cancer. 1993;71:338-45.
45. Choong PF, Pritchard DJ, Rock MG, Sim FH, McLeod RA, Unni KK. Low grade central osteogenic sarcoma. A long-term followup of 20 patients. Clin Orthop Relat Res. 1996;322:198-206.
46. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S. Osteoprotegerin deficiency and juvenile Paget's disease. New Engl J Med. 2002;347:175-84.
47. Janssens K, de Vernejoul MC, de Freitas F, Vanhoenacker F, Van Hul W. An intermediate form of juvenile Paget's disease caused by truncating TNFRSF11B mutation. Bone. 2005;36:542-8.
48. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997;12:1746-52.
49. Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994;343:953-4.
50. Chapurlat R, Meunier PJ. Fibrous dysplasia of bone. Baillieres Best Pract Res Clin Rheumatol. 2000;14:385-98.
51. US Food and Drug Administration. MedWatch. The FDA Safety Information and Adverse Event Reporting Program. Zometa (zoledronic acid) injection. www.fda.gov/medwatch/SAFETY/2004/safety04.htm#zometa. Accessed March 2, 2005.
52. Lane JM, Khan SN, O'Connor WJ, Nydick M, Hommen JP, Schneider R, Tomin E, Brand J, Curtin J. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res. 2001;382:6-12.
53. Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr. 2000;137:403-9.
54. Pfeilschifter J, Ziegler R. [Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome]. Med Klin (Munich). 1998;93:352-9. German.
55. Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr. 2000;89:188-93.
56. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab. 2003;88:4569-75.
57. Weinstein RS. Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density. J Bone Miner Res. 1997;12:1314-5.
58. Parisi MS, Oliveri B, Mautalen CA. Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia. Bone. 2003;33:582-8.
59. O'Sullivan M, Zacharin M. Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome. J Pediatr Orthop. 2002;22:255-60.
60. Stephenson RB, London MD, Hankin FM, Kaufer H. Fibrous dysplasia. An analysis of options for treatment. J Bone Joint Surg Am. 1987;69:400-9.
61. Kumta SM, Leung PC, Griffith JF, Kew J, Chow LT. Vascularized bone grafting for fibrous dysplasia of the upper limb. J Bone Joint Surg Br. 2000;82:409-12.
62. Connolly JF. Shepherd's Crook deformities of polyostotic fibrous dysplasia treated by osteotomy and Zickel nail fixation. Clin Orthop Relat Res. 1977;123:22-4.
63. Freeman BH, Bray EW 3rd, Meyer LC. Multiple osteotomies with Zickel nail fixation for polyostotic fibrous dysplasia involving the proximal part of the femur. J Bone Joint Surg Am. 1987;69:691-8.
64. Ippolito E, Caterini R, Farsetti P, Potenza V. Surgical treatment of fibrous dysplasia of bone in McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2002;15 Suppl 3:939-44.
65. Collins MT, Kushner H, Reynolds JC, Chebli C, Kelly MH, Gupta A, Brillante B, Leet AI, Riminucci M, Robey PG, Bianco P, Wientroub S, Chen CC. An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res. 2005;20:219-26.